Cart
sales@molnova.com
Dihydrocurcumin
CAS No. 76474-56-1
Dihydrocurcumin( —— )
Catalog No. M35174 CAS No. 76474-56-1
Dihydrocurcumin is the main metabolite of curcumin, which can reduce fat accumulation and oxidative stress response.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 195 | Get Quote |
|
| 5MG | 217 | Get Quote |
|
| 10MG | 359 | Get Quote |
|
| 25MG | 617 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDihydrocurcumin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydrocurcumin is the main metabolite of curcumin, which can reduce fat accumulation and oxidative stress response.
-
DescriptionDihydrocurcumin, a major metabolites of curcumin, reduces lipid accumulation and oxidative stress. Dihydrocurcumin regulates mRNA and protein expression levels of SREBP-1C, PNPLA3 and PPARα, increases protein expression levels of pAKT and PI3K, and reduced the levels of cellular NO and ROS via Nrf2 signaling pathways.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR | Fatty Acid Synthase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76474-56-1
-
Formula Weight370.4
-
Molecular FormulaC21H22O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (67.49 mM; Ultrasonic (<60°C)
-
SMILESCOc1cc(CCC(=O)\C=C(/O)\C=C\c2ccc(O)c(OC)c2)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu Q, et al. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells. Biomed Pharmacother. 2018 Jul;103:1327-1336.?
molnova catalog
related products
-
BAY-0069
BAY-0069 is a potent and selective PPARγ transactivator, inhibiting human PPARγ and murine PPARγ with IC50 values of 6.3 nM and 24 nM, respectively. BAY-0069 can be used in cancer research.
-
CUDA
CUDA is an effective soluble cyclohydrolase inhibitor with IC50 of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively.
-
Furegrelate sodium
Furegelate sodium is a selective thromboxane synthase inhibitor with oral activity.
